Gujarat Inject [GUJINJEC] vs Zota Health Care [ZOTA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Gujarat Inject (Kerala) Ltd. wins in 10 metrics, Zota Health Care Limited wins in 7 metrics, with 1 ties. Gujarat Inject (Kerala) Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Gujarat Inject (Kerala) Ltd. | Zota Health Care Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 158.27 | -62.53 | Gujarat Inject (Kerala) Ltd. |
| Price-to-Book Ratio | 12.63 | 12.61 | Zota Health Care Limited |
| Debt-to-Equity Ratio | 0.00 | 56.90 | Tie |
| PEG Ratio | -2.01 | -0.59 | Zota Health Care Limited |
| EV/EBITDA | 93.74 | -126.59 | Gujarat Inject (Kerala) Ltd. |
| Profit Margin (TTM) | 2.51% | -15.37% | Gujarat Inject (Kerala) Ltd. |
| Operating Margin (TTM) | 2.88% | -15.88% | Gujarat Inject (Kerala) Ltd. |
| EBITDA Margin (TTM) | 2.88% | N/A | N/A |
| Return on Equity | 10.16% | -24.83% | Gujarat Inject (Kerala) Ltd. |
| Return on Assets (TTM) | 8.51% | -12.84% | Gujarat Inject (Kerala) Ltd. |
| Free Cash Flow (TTM) | $-15.46M | $-959.42M | Gujarat Inject (Kerala) Ltd. |
| Dividend Yield | N/A | 0.07% | N/A |
| 1-Year Return | 425.15% | 27.17% | Gujarat Inject (Kerala) Ltd. |
| Price-to-Sales Ratio (TTM) | 13.82 | 8.34 | Zota Health Care Limited |
| Enterprise Value | $1.18B | $45.66B | Zota Health Care Limited |
| EV/Revenue Ratio | 11.69 | 9.66 | Zota Health Care Limited |
| Gross Profit Margin (TTM) | 0.14% | 60.28% | Zota Health Care Limited |
| Revenue per Share (TTM) | $11 | $157 | Zota Health Care Limited |
| Earnings per Share (Diluted) | $0.60 | $-23.94 | Gujarat Inject (Kerala) Ltd. |
| Beta (Stock Volatility) | -0.90 | 0.36 | Gujarat Inject (Kerala) Ltd. |
Gujarat Inject (Kerala) Ltd. vs Zota Health Care Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Gujarat Inject (Kerala) Ltd. | -1.68% | -2.42% | 13.59% | 63.41% | 279.75% | 225.27% |
| Zota Health Care Limited | 1.75% | 3.68% | 3.22% | 14.06% | -26.10% | -17.99% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Gujarat Inject (Kerala) Ltd. | 425.15% | 1,090.00% | 3,947.62% | 3,947.62% | 3,947.62% | 3,947.62% |
| Zota Health Care Limited | 27.17% | 243.00% | 632.12% | 1,248.00% | 1,248.00% | 1,248.00% |
Performance & Financial Health Analysis: Gujarat Inject (Kerala) Ltd. vs Zota Health Care Limited
| Metric | GUJINJEC | ZOTA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.38B | ₹39.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 22,292 | 56,411 |
| 90 Day Avg. Volume | 41,507 | 53,265 |
| Last Close | ₹117.00 | ₹1,246.70 |
| 52 Week Range | ₹19.01 - ₹125.50 | ₹917.20 - ₹1,740.00 |
| % from 52W High | -6.77% | -28.35% |
| All-Time High | ₹125.50 (Jun 09, 2026) | ₹1,740.00 (Nov 21, 2025) |
| % from All-Time High | -6.77% | -28.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.44% | 0.98% |
| Quarterly Earnings Growth | -0.82% | 1.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | -0.15% |
| Operating Margin (TTM) | 0.03% | -0.16% |
| Return on Equity (TTM) | 0.10% | -0.25% |
| Debt to Equity (MRQ) | 0.00 | 56.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹7.52 | ₹103.04 |
| Cash per Share (MRQ) | ₹0.18 | ₹1.87 |
| Operating Cash Flow (TTM) | ₹-31,076,498 | ₹-1,007,999,000 |
| Levered Free Cash Flow (TTM) | ₹10.17M | ₹-563,984,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.07% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Gujarat Inject (Kerala) Ltd. vs Zota Health Care Limited
| Metric | GUJINJEC (Apr 24, 2026) | ZOTA (Apr 22, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 158.27 | -62.53 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -2.01 | -0.59 |
| Price to Sales (TTM) | 13.82 | 8.34 |
| Price to Book (MRQ) | 12.63 | 12.61 |
| Market Capitalization | ||
| Market Capitalization | ₹1.38B | ₹39.41B |
| Enterprise Value | ₹1.18B | ₹45.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.69 | 9.66 |
| Enterprise to EBITDA | 93.74 | -126.59 |
| Risk & Other Metrics | ||
| Beta | -0.90 | 0.36 |
| Book Value per Share (MRQ) | ₹7.52 | ₹103.04 |
Financial Statements Comparison: Gujarat Inject (Kerala) Ltd. vs Zota Health Care Limited
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GUJINJEC (2025) | ZOTA (2025) |
|---|---|---|
| Revenue/Sales | 190.46M | 2.93B |
| Cost of Goods Sold | 177.77M | 1.44B |
| COGS % of Revenue | 93.3% | 49.0% |
| Gross Profit | 12.68M | 1.49B |
| Gross Margin | 6.7% | 51.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 10.75M | -480.90M |
| Operating Margin | 5.6% | -16.4% |
| EBITDA | 12.56M | -42.20M |
| EBITDA Margin | 6.6% | -1.4% |
| Pre-Tax Income | 12.54M | -576.44M |
| Pre-Tax Income % of Revenue | 6.6% | -19.7% |
| Income Tax | 2.37M | -9.06M |
| Income Tax % of Revenue | 1.2% | -0.3% |
| Net Income (Profit) | 10.17M | -567.39M |
| Profit Margin | 5.3% | -19.4% |
Balance Sheet & Liquidity Metrics
| Metric | GUJINJEC (2025) | ZOTA (2025) |
|---|---|---|
| Cash & Equivalents | 262,785 | 21.32M |
| Total Current Assets | 99.75M | 1.84B |
| Total Current Assets % of Revenue | 52.4% | 62.9% |
| Total Current Liabilities | 19.38M | 1.01B |
| Total Current Liabilities % of Revenue | 10.2% | 34.3% |
| Long-Term Debt | 0 | 1.08B |
| Long-Term Debt % of Revenue | 0.0% | 36.7% |
| Total Shareholders Equity | 100.12M | 2.27B |
| Retained Earnings | N/A | -191.89M |
| Retained Earnings % of Revenue | 0.0% | -6.5% |
| Property, Plant & Equipment | N/A | 65.25M |
Cash Flow Statement Comparison
| Metric | GUJINJEC (2025) | ZOTA (2025) |
|---|---|---|
| Operating Cash Flow | -31.08M | -1.01B |
| Operating Cash Flow % of Revenue | -16.3% | -34.4% |
| Capital Expenditures | 0 | -459.67M |
| Free Cash Flow | -15.46M | -959.42M |
| FCF Margin | -8.1% | -32.7% |
| Debt Repayment | -19.76M | -140.67M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GUJINJEC | ZOTA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 14.65M | 30.33M |
| Float Shares | 1.00M | 15.02M |
| % Held by Insiders | 63.90% | 0.00% |
| % Held by Institutions | 0.00% | 1.16% |
| % Held by Public | 36.10% | 98.84% |
Dividend Analysis & Yield Comparison: Gujarat Inject (Kerala) Ltd. vs Zota Health Care Limited
| Metric | GUJINJEC | ZOTA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.07% |
| 3-Year Avg Annual Dividend | N/A | ₹1.00 |
| 3-Year Avg Dividend Yield | N/A | 0.16% |
| 3-Year Total Dividends | N/A | ₹3.00 |
| Ex-Dividend Date | N/A | Sep 22, 2025 |